Armata Pharmaceuticals, Inc. (ARMP)
5.795
+0.28
(+4.98%)
USD |
NYAM |
Sep 04, 13:57
Armata Pharmaceuticals Gross Profit Margin (Quarterly) : 76.45% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.45% |
| March 31, 2026 | 42.08% |
| December 31, 2025 | 61.47% |
| September 30, 2025 | 68.08% |
| June 30, 2025 | 83.13% |
| March 31, 2025 | 23.22% |
| December 31, 2024 | 69.23% |
| September 30, 2024 | 89.91% |
| June 30, 2024 | |
| March 31, 2024 | 67.18% |
| December 31, 2023 | 80.82% |
| September 30, 2023 | 81.96% |
| June 30, 2023 | 79.59% |
| March 31, 2023 | 71.11% |
| December 31, 2022 | 76.69% |
| September 30, 2022 | 83.11% |
| June 30, 2022 | 89.64% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -380.0% |
| September 30, 2017 | -144.7% |
| June 30, 2017 | -228.6% |
| March 31, 2017 | -220.7% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 35.29% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -230.8% |
| Return on Invested Capital | -259.1% |
| Operating Margin (Quarterly) | -410.8% |
| Return on Net Operating Assets | -310.2% |